Galvin Gaustad & Stein’s Labcorp LH Stock Holding History

Galvin Gaustad & Stein’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-899	Closed	-$226K	–	264
2025 Q4	$226K	Hold	899	–	–	0.02%	239
2025 Q3	$258K	Sell	899 -237	-21%	-$63.5K	0.02%	186
2025 Q2	$298K	Sell	1,136 -74,638	-99%	-$18.2M	0.03%	163
2025 Q1	$17.6M	Sell	75,774 -11,638	-13%	-$2.82M	1.58%	24
2024 Q4	$20M	Sell	87,412 -1,098	-1%	-$252K	1.8%	20
2024 Q3	$19.8M	Sell	88,510 -623	-0.7%	-$137K	1.76%	20
2024 Q2	$18.1M	Sell	89,133 -4,752	-5%	-$967K	1.69%	22
2024 Q1	$20.5M	Sell	93,885 -3,294	-3%	-$726K	1.89%	21
2023 Q4	$22.1M	Sell	97,179 -756	-0.8%	-$159K	2.07%	17
2023 Q3	$19.7M	Buy	+97,935	New	+$20.7M	2%	15

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Galvin Gaustad & Stein's LH Position: Q1 2026 in Review

Galvin Gaustad & Stein sold out of Labcorp (LH) in Q1 2026, closing a stake of 899 shares — an estimated $226K sold.

Galvin Gaustad & Stein first reported a position in LH in Q3 2023 and held it in 10 quarters. The position peaked at $22.1M in Q4 2023. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

Galvin Gaustad & Stein reported no remaining Labcorp position as of Q1 2026 after selling out during the quarter.
Galvin Gaustad & Stein sold 899 Labcorp shares in Q1 2026, an estimated $226K.
Galvin Gaustad & Stein first reported a position in Labcorp in Q3 2023 and held it in 10 quarters.
Galvin Gaustad & Stein's Labcorp position peaked at $22.1M in Q4 2023.
1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Galvin Gaustad & Stein's 13F filing for Q1 2026, filed 14 May 2026.